A D S Diagnostic Ltd
₹ 11.3
5.00%
17 Apr 2014
About
ADS Diagnostic supplies and trades medical equipment. The Company offers patient monitoring systems and ultrasound machines.
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹ 11.3
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 29.9
- Dividend Yield 10.6 %
- ROCE 40.8 %
- ROE 35.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.38 times its book value
- Company's working capital requirements have reduced from 144 days to 99.0 days
Cons
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5.59 | 7.33 | 7.44 | 11.67 | 5.26 | 6.38 | 8.95 | 13.52 | 9.43 | 10.10 | 13.29 | 23.96 | 23.23 | |
5.46 | 6.93 | 6.75 | 10.38 | 6.01 | 5.65 | 7.41 | 12.96 | 9.33 | 9.11 | 11.79 | 20.83 | 20.79 | |
Operating Profit | 0.13 | 0.40 | 0.69 | 1.29 | -0.75 | 0.73 | 1.54 | 0.56 | 0.10 | 0.99 | 1.50 | 3.13 | 2.44 |
OPM % | 2.33% | 5.46% | 9.27% | 11.05% | -14.26% | 11.44% | 17.21% | 4.14% | 1.06% | 9.80% | 11.29% | 13.06% | 10.50% |
0.05 | 0.10 | 0.11 | -0.14 | 0.82 | 0.29 | 0.18 | 0.81 | 1.19 | 0.36 | -0.38 | 0.10 | 0.00 | |
Interest | 0.12 | 0.20 | 0.31 | 0.42 | 0.55 | 0.51 | 0.45 | 0.48 | 0.56 | 0.51 | 0.44 | 0.57 | 0.48 |
Depreciation | 0.20 | 0.20 | 0.30 | 0.21 | 0.16 | 0.15 | 0.16 | 0.27 | 0.29 | 0.28 | 0.19 | 0.16 | 0.16 |
Profit before tax | -0.14 | 0.10 | 0.19 | 0.52 | -0.64 | 0.36 | 1.11 | 0.62 | 0.44 | 0.56 | 0.49 | 2.50 | 1.80 |
Tax % | -21.43% | 70.00% | 57.89% | 42.31% | -18.75% | 41.67% | 22.52% | 24.19% | 25.00% | 23.21% | 16.33% | 26.00% | |
-0.11 | 0.04 | 0.08 | 0.31 | -0.52 | 0.21 | 0.85 | 0.47 | 0.34 | 0.44 | 0.41 | 1.85 | 1.29 | |
EPS in Rs | -0.50 | 0.18 | 0.36 | 1.41 | -2.37 | 0.96 | 3.88 | 2.14 | 1.55 | 2.01 | 1.87 | 8.44 | 5.88 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 23.82% | 0.00% | 0.00% | 40.91% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 22% |
3 Years: | 36% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 47% |
5 Years: | 17% |
3 Years: | 76% |
TTM: | -41% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 20% |
3 Years: | 25% |
Last Year: | 36% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 |
Reserves | -0.13 | -0.09 | -0.10 | 0.21 | -0.31 | -0.10 | 0.77 | 1.07 | 1.41 | 1.85 | 2.13 | 3.77 | 4.31 |
2.44 | 2.00 | 2.19 | 4.45 | 4.19 | 3.79 | 1.81 | 5.51 | 5.29 | 3.99 | 2.54 | 2.09 | 1.07 | |
1.78 | 2.32 | 2.67 | 7.17 | 2.35 | 4.18 | 11.93 | 8.54 | 5.63 | 3.92 | 5.05 | 7.82 | 8.70 | |
Total Liabilities | 6.34 | 6.48 | 7.01 | 14.08 | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 16.33 |
0.91 | 0.73 | 1.06 | 1.58 | 1.38 | 1.11 | 2.10 | 1.84 | 1.55 | 1.15 | 0.37 | 0.22 | 0.29 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
5.43 | 5.75 | 5.95 | 12.50 | 7.06 | 8.97 | 14.62 | 15.49 | 12.99 | 10.82 | 11.56 | 15.67 | 16.00 | |
Total Assets | 6.34 | 6.48 | 7.01 | 14.08 | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 16.33 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.46 | 0.80 | 1.16 | 1.14 | -1.60 | 0.89 | 3.82 | -3.98 | 0.53 | 1.74 | 1.44 | 0.48 | |
0.01 | -0.46 | -1.15 | -0.88 | 0.62 | 0.15 | -1.07 | 0.08 | 0.09 | 0.24 | 0.68 | 0.06 | |
-0.16 | -0.20 | -0.22 | -0.50 | 1.13 | 0.09 | -2.35 | 2.83 | -0.09 | -2.00 | -3.18 | 0.28 | |
Net Cash Flow | 0.31 | 0.14 | -0.21 | -0.23 | 0.15 | 1.13 | 0.41 | -1.07 | 0.53 | -0.03 | -1.06 | 0.83 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 72.48 | 56.77 | 60.34 | 182.97 | 136.01 | 127.01 | 106.44 | 137.68 | 174.57 | 123.59 | 75.53 | 78.76 |
Inventory Days | 274.24 | 199.41 | 237.59 | 196.37 | 283.74 | 280.52 | 186.28 | |||||
Days Payable | 138.11 | 175.38 | 200.86 | 203.85 | 161.19 | 171.67 | 79.83 | |||||
Cash Conversion Cycle | 208.61 | 80.80 | 97.07 | 175.50 | 258.56 | 127.01 | 106.44 | 137.68 | 174.57 | 123.59 | 184.38 | 185.20 |
Working Capital Days | 160.63 | 78.18 | 57.40 | 104.78 | 172.09 | 147.03 | 11.42 | 121.49 | 218.69 | 190.45 | 142.81 | 99.02 |
ROCE % | -0.47% | 6.88% | 12.24% | 22.93% | -0.77% | 15.74% | 28.97% | 16.11% | 11.25% | 12.09% | 23.85% | 40.85% |
Documents
Announcements
-
Board Meeting Outcome for Outcome Of The Board Meeting For The Quarter/Half Year Ended September 30, 2024 - SEBI (LODR) Regulations, 2015
14 Nov - Board approved unaudited financial results for Q2 2024.
-
Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.
4 Nov - Notice of Board Meeting for financial results.
-
Compliance Under Regulation 6(1) And 7(1) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation -2015 For The Quarter Ended 30.09.2024.
25 Oct - Appointment of Company Secretary and Compliance Officer.
-
Delayed Submission Of Proceedings Of General Meetings
4 Oct - Explanation for delayed submission of AGM proceedings.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep - Results of 39th AGM and e-voting outcomes.